Sign in Welcome! Log into your account your username your password Forgot your password? Get help Password recovery Recover your password your email A password will be e-mailed to you. Spectrum Pharmaceuticals Appoints Elizabeth Czerepak to its Board of Directors By Admin June 20, 2019 NewslettersLook Who’s On the Move! Share Facebook Twitter Pinterest WhatsApp Linkedin Email Print HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals Appoints Elizabeth Czerepak to its Board of Directors…. http://www.businesswire.com/news/home/20190620005105/en/Spectrum-Pharmaceuticals-Appoints-Elizabeth-Czerepak-Board-Directors First Name * Email * Last Name * Country * Lists 02_NEWSLETTER: ANNOUNCEMENTS 02_NEWSLETTER: BIOTECHNOLOGY 02_NEWSLETTER: EDITOR´S PICK 02_NEWSLETTER: FEATURED ARTICLE 02_NEWSLETTER: HOSPITAL NEWS 02_NEWSLETTER: INDUSTRY NEWS 02_NEWSLETTER: LOOK WHO IS ON THE 02_NEWSLETTER: MEDICAL DEVICES 03_NEWSLETTER: NATALIE YEADON 02_NEWSLETTER: REGULATORY AFFAIRS 02_NEWSLETTER: CLINICAL TRIALS Recent Articles HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration Industry News March 1, 2021 Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie Industry News March 1, 2021 Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics Industry News February 26, 2021 BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan Industry News February 26, 2021 SYLVANT® (siltuximab) Recommended by the National Comprehensive Cancer Network® (NCCN®) as the Preferred Treatment Option for Patients with Idiopathic Multicentric Castleman Disease (iMCD) regardless... Industry News February 26, 2021 Sign in / Join